S&P 500 7,387.05 â–ŧ 197.26 (-2.60%) DOW 50,877.30 â–ŧ 684.63 (-1.33%) NASDAQ 25,726.49 â–ŧ 1,104.47 (-4.12%) US Markets Closed â€ĸ 10:23 PM ET

ADIA

Adia Nutrition, Inc.

Price Chart
Latest Quote

$0.15

+0.00 (+0.00%)
Current Price
Previous Close $0.15
Open $0.12
Day High $0.15
Day Low $0.12
Volume 32,486
Fetched: 2026-06-06T02:22:58
Stock Information
Shares Outstanding 94.40M
Total Debt $902K
Cash Equivalents $137K
Revenue $805K
Net Income $-442K
Sector Financial Services
Industry Shell Companies
Market Cap $14.16M
Exchange OQB
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Enterprise Value$15.08M
Sales$805K
Income$-442K
Book/sh$-0.01
Cash/sh$0.00
Employees3
Financial Ratios
Quick Ratio0.20
Current Ratio0.32
Returns & Margins
Gross Margin29.34%
Operating Margin-86.18%
Profit Margin-54.88%
Ownership
Insider & Institutional transactions data not available
Valuation Ratios
P/S17.59
P/B-25.00
Analyst Data
Recommendationnone
Technical Indicators
SMA20$0.16
SMA50$0.16
SMA200$0.11
RSI38.89
ATR0.0251
Shares Float72.40M
Volatility-8.54
Rel Volume4.37
Performance History
Week-11.76%
Month+0.00%
Quarter-26.83%
6 Months+92.31%
YTD+114.29%
Year+114.29%
3 Years+435.71%
5 Years+782.35%
10 Years+1150.00%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-06-05 $0.15 82,500
2026-06-04 $0.15 42,500
2026-06-03 $0.15 4,300
2026-06-02 $0.15 49,500
2026-06-01 $0.15 14,300
2026-05-29 $0.17 47,500
2026-05-28 $0.16 68,100
2026-05-27 $0.16 0
2026-05-26 $0.16 0
2026-05-22 $0.16 0
2026-05-21 $0.16 1,800
2026-05-20 $0.17 6,300
2026-05-19 $0.17 1,700
2026-05-18 $0.15 46,100
2026-05-15 $0.17 2,700
2026-05-14 $0.17 1,100
2026-05-13 $0.17 0
2026-05-12 $0.17 2,200
2026-05-11 $0.17 3,000
2026-05-08 $0.16 4,000
2026-05-07 $0.17 3,300
2026-05-06 $0.15 2,400
About Adia Nutrition, Inc.

Adia Nutrition, Inc. offers medical treatments and nutritional supplements. The company operates in three segments: Biolete, Adia Med, and Adia Labs. It provides autologous hematopoietic stem cell transplantation (AHSCT) treatments for multiple sclerosis patients. The company also operates Adia Med, a clinic to perform stem cell treatments, and Adia Labs, which procures and sells stem cell products to outside clinics or Adia Med. In addition, the company offers nutritional supplements and biologic products. It sells its products on a direct-to-consumer basis, as well as through other direct to consumer channels. The company was formerly known as PivX Solutions Inc. and changed its name to Adia Nutrition, Inc. in May 2004. Adia Nutrition, Inc. is based in Winter Park, Florida.

📰 Latest News
No news articles available at the moment. Check back later for updates on ADIA.
Period:
Loading...
Income Statement (Annual)
Metric 2025-12-31 2024-12-31
Revenue
Reconciled Cost Of Revenue $434,408 $4,186
Cost Of Revenue $508,838 $4,186
Total Revenue $700,508 $6,380
Operating Revenue $700,508 $6,380
Expenses
Interest Expense $31,597 $6,318
Total Expenses $1,067,000 $181,129
Rent Expense Supplemental $96,420 $10,583
Other Income Expense $2,000 -
Other Non Operating Income Expenses $2,000 -
Net Non Operating Interest Income Expense $-30,972 $-6,318
Interest Expense Non Operating $31,597 $6,318
Operating Expense $558,162 $176,943
Other Operating Expenses $56,520 -
Selling And Marketing Expense $78,207 $36,534
General And Administrative Expense $389,852 $139,976
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-395,464 $-181,067
Net Interest Income $-30,972 $-6,318
Interest Income $625 $0
Normalized Income $-395,464 $-181,067
Net Income From Continuing And Discontinued Operation $-395,464 $-181,067
Total Operating Income As Reported $-366,492 $-174,749
Net Income Common Stockholders $-395,464 $-181,067
Net Income $-395,464 $-181,067
Net Income Including Noncontrolling Interests $-395,464 $-181,067
Net Income Continuous Operations $-395,464 $-181,067
Pretax Income $-395,464 $-181,067
Interest Income Non Operating $625 $0
Operating Income $-366,492 $-174,749
Depreciation Amortization Depletion Income Statement $4,439 $433
Depreciation And Amortization In Income Statement $4,439 $433
Gross Profit $191,670 $2,194
Per Share
Diluted EPS - $0.00
Basic EPS - $0.00
Other
Tax Effect Of Unusual Items $0 $0
Tax Rate For Calcs $0 $0
Normalized EBITDA (Bullshit earnings) $-284,998 $-165,929
Reconciled Depreciation $78,869 $8,820
EBITDA (Bullshit earnings) $-284,998 $-165,929
EBIT $-363,867 $-174,749
Diluted NI Availto Com Stockholders $-395,464 $-181,067
Tax Provision $0 $0
Research And Development $29,144 $0
Selling General And Administration $468,059 $176,510
Other Gand A $189,415 $98,536
Rent And Landing Fees $96,420 $10,583
Salaries And Wages $104,017 $30,857
Diluted Average Shares - $91,735,477
Basic Average Shares - $91,735,477
Fetched: 2026-04-15
Balance Sheet (Annual)
Metric 2025-12-31 2024-12-31
Assets
Net Tangible Assets $-257,674 $19,630
Total Assets $594,826 $666,181
Total Non Current Assets $433,316 $407,788
Non Current Prepaid Assets $10,000 $10,000
Non Current Note Receivables $25,000 $0
Non Current Accounts Receivable $72,107 -
Goodwill And Other Intangible Assets $0 $5,910
Current Assets $161,510 $258,393
Prepaid Assets $23,483 $184,434
Inventory $25,025 $67,636
Receivables $33,610 $0
Accrued Interest Receivable $250 $0
Accounts Receivable $33,360 $0
Cash Cash Equivalents And Short Term Investments $79,392 $6,323
Cash And Cash Equivalents $79,392 $6,323
Cash Financial $79,392 $6,323
Other Intangible Assets - $5,910
Debt
Net Debt $520,608 $362,206
Total Debt $798,039 $629,447
Long Term Debt And Capital Lease Obligation $707,305 $560,648
Long Term Debt $600,000 $368,529
Current Debt And Capital Lease Obligation $90,734 $68,799
Liabilities
Total Liabilities Net Minority Interest $852,500 $640,641
Total Non Current Liabilities Net Minority Interest $707,305 $560,648
Current Liabilities $145,195 $79,993
Current Deferred Liabilities $14,000 $0
Payables And Accrued Expenses $40,461 $11,194
Interest Payable $37,915 $6,318
Payables $2,393 $4,876
Accounts Payable $2,393 $4,876
Equity
Common Stock Equity $-259,425 $13,789
Preferred Stock Equity $1,751 $11,751
Total Equity Gross Minority Interest $-257,674 $25,540
Stockholders Equity $-257,674 $25,540
Other Equity Interest $152,607 $110,357
Retained Earnings $-15,973,482 $-15,578,018
Long Term Equity Investment $79,500 $79,500
Other
Ordinary Shares Number $94,404,696 $95,899,861
Share Issued $94,404,696 $95,899,861
Tangible Book Value $-259,425 $7,879
Invested Capital $340,575 $382,318
Working Capital $16,315 $178,400
Capital Lease Obligations $198,039 $260,918
Total Capitalization $342,326 $394,069
Additional Paid In Capital $15,467,045 $15,385,550
Capital Stock $96,156 $107,651
Common Stock $94,405 $95,900
Preferred Stock $1,751 $11,751
Long Term Capital Lease Obligation $107,305 $192,119
Current Deferred Revenue $14,000 $0
Current Capital Lease Obligation $90,734 $68,799
Current Accrued Expenses $38,068 $6,318
Investments And Advances $79,500 $79,500
Net PPE $246,709 $312,378
Accumulated Depreciation $-4,335 $-194
Gross PPE $251,044 $312,572
Other Properties $216,014 $290,741
Machinery Furniture Equipment $35,030 $21,831
Other Inventories $25,025 -
Finished Goods $0 $67,636
Fetched: 2026-04-15
Cash Flow Statement (Annual)
Metric 2025-12-31 2024-12-31
Free Cash Flow
Free Cash Flow $-192,428 $-361,456
Operating Activities
Operating Cash Flow $-179,228 $-335,476
Cash Flow From Continuing Operating Activities $-179,228 $-335,476
Operating Gains Losses $-239 -
Investing Activities
Capital Expenditure $-13,200 $-25,980
Investing Cash Flow $-32,051 $-25,980
Cash Flow From Continuing Investing Activities $-32,051 $-25,980
Net Other Investing Changes $-25,000 -
Financing Activities
Issuance Of Capital Stock $70,000 $25,000
Financing Cash Flow $284,348 $367,279
Cash Flow From Continuing Financing Activities $284,348 $367,279
Net Common Stock Issuance $70,000 $25,000
Common Stock Issuance $70,000 $25,000
Other
Repayment Of Debt $-17,123 $-25,000
Interest Paid Supplemental Data $0 $0
Income Tax Paid Supplemental Data $0 $0
End Cash Position $79,392 $6,323
Beginning Cash Position $6,323 $500
Changes In Cash $73,069 $5,823
Net Issuance Payments Of Debt $214,348 $342,279
Net Long Term Debt Issuance $214,348 $342,279
Long Term Debt Payments $-17,123 $-25,000
Net Intangibles Purchase And Sale $6,149 $-4,149
Sale Of Intangibles $6,149 $0
Purchase Of Intangibles $0 $-4,149
Net PPE Purchase And Sale $-13,200 $-21,831
Purchase Of PPE $-13,200 $-21,831
Change In Working Capital $95,356 $-194,086
Change In Other Working Capital $14,000 -
Change In Other Current Liabilities $-45,756 $-13,209
Change In Payables And Accrued Expense $29,267 $11,194
Change In Accrued Expense $31,750 $6,318
Change In Payable $-2,483 $4,876
Change In Account Payable $-2,483 $4,876
Change In Prepaid Assets $160,951 $-55,185
Change In Inventory $-29,496 $-136,886
Change In Receivables $-33,610 $0
Changes In Account Receivables $-33,360 $0
Stock Based Compensation $42,250 $30,857
Depreciation Amortization Depletion $78,869 $8,820
Depreciation And Amortization $78,869 $8,820
Depreciation $78,869 $8,820
Gain Loss On Sale Of PPE $-239 $0
Net Income From Continuing Operations $-395,464 $-181,067
Fetched: 2026-04-15